Senate Members

Dr Stewart Washer

Dr Stewart Washer

Stewart has over 17 years of senior executive and Board experience in commercial technology companies in the medical, food, agricultural and industrial sectors. He has raised over $50m in private shareholder and government funds to invest in his companies and was a founder of Biopacific Ventures, a $120m New Zealand based fund. He is currently a Venture Partner with the Swiss Inventages Fund, a €1.5 billion life science fund.

Stewart was most recently the founding CEO of Phylogica Ltd (ASX:PYC) a company with a peptide drug discovery platform that is developing peptide based drugs for inflammatory diseases including burns treatment and RA. Before this, he was CEO of Celentis and managed the commercialisation of intellectual property from AgResearch in New Zealand with 650 Scientists and $130m revenues. During this time he formed and governed a number of successful biotechnology companies that employed over 100 people with profitable revenues in excess of $30m.

Stewart is an Executive Director of Xceed Capital Ltd (ASX:XCD) who own PolyNovo P/L, a novel biodegradable polymer company and Boron Molecular P/L a profitable chemistry company. Stewart is also a Director of Genesis (ASX:GEN) who are developing siRNA drugs against cancer and have spun off a novel bioenergy and lignin company based in New Zealand. He is also the Chairman of Hatchtech Pty Ltd who have a novel anti pest egg hatching technology and are in clinical trials with a headlice treatment and a Director of Healthlinx (ASX:HTX) who have developed the first successful diagnostic for Ovarian Cancer. Stewart sits on the Federal Government Advisory Panel for Industrial Biotechnology.

Senate Membership List